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RESEARCH
Utilization of traditional, complementary 
and alternative medicine and mental health 
among patients with chronic diseases 
in primary health care settings in Cambodia
Siyan Yi1,2* , Chanrith Ngin1, Sovannary Tuot1, Pheak Chhoun1, Tyler Fleming2 and Carinne Brody2
Abstract 
Background: Coping with chronic illnesses often involves major lifestyle changes that may lead to poor mental 
health. Furthermore, in order to treat the chronic conditions, many sufferers in Asia turn to traditional, complementary 
and alternative medicines (TCAM). This study explores prevalence of TCAM use and factors associated with anxiety 
and depressive symptoms among patients with chronic diseases in Cambodia.
Methods: In 2015, this cross-sectional study was conducted with outpatients receiving treatment and care for 
chronic diseases in two urban and two rural primary health centers. Every eligible patient was randomly selected at 
the health centers using a systematic sampling procedure. Symptoms of anxiety and depression were assessed by 
using the Hospital Anxiety and Depression Scale (HADS). Multivariate logistic regression models were constructed to 
explore factors associated with anxiety and depressive symptoms.
Results: The study participants included 1528 patients, of whom 77.2% were female, with a mean age of 46.5 years 
(SD = 15.3). After adjustment, patients with depressive symptoms remained significantly more likely to be in the age 
groups between 41 and 60 years old and to be married, separated/divorced or widowed compared to those without 
depressive symptoms. Regarding the use of TCAM, patients with depressive symptoms remained significantly more 
likely to report using an herbalist, practicing visualization and praying for own health, but less likely to report using 
vitamins or supplements in the past 12 months. For quality of life, patients with depressive symptoms remained sig-
nificantly less likely to agree that they had enough energy for their everyday life and had enough money to meet their 
daily needs. Similar risk factors were also found to be significantly associated with anxiety symptoms.
Conclusions: Cambodian patients with chronic diseases who experienced symptoms of anxiety or depression were 
more likely to report reduced quality of life, greater chronic disease-related stigma and more TCAM use. Given the 
potential interaction of TCAM, mental health and other chronic conditions, a history of TCAM use and mental health 
should be elicited in clinical practices in primary health care settings, particularly in developing countries.
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Background
Chronic diseases cause significant morbidity and mor-
tality in Southeast Asia. In the last 10 years, deaths due 
to chronic diseases among those aged 10–54 increased 
by 10% [1]. Chronic diseases not only negatively impact 
health, but also cause undue burden due to unemploy-
ment, laborious treatments, restricted mobility and loss 
of independence [2–5]. Cambodia is not exempt from the 
effect of chronic diseases. From 2005 to 2015, the num-
ber of years lost due to chronic diseases increased by 
10% for people aged 10–54 in the Kingdom [1]. A 2005 
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study found that 30% of participants in Siem Reap and 
56% of participants in Kampong Cham suffered from 
some form of glucose intolerance, hypertension or both 
[6]. In a country torn apart by the Khmer Rouge regime, 
psychological disorders are also pervasive. In the 2012 
Cambodian Mental Health Survey, 32% of women and 
18% of men demonstrated symptoms of anxiety, and 20% 
of women and 10% of men demonstrated symptoms of 
depression [1, 7].
Past research from throughout Asia indicates that 
adults with chronic illnesses are more likely to experience 
anxiety and depression as comorbidities. Patients with 
ischemic heart disease had a higher anxiety score than 
those without heart disease in a 2014 study from Malay-
sia [8]. Moreover, anxiety and panic disorders were more 
prevalent in patients with chronic obstructive pulmonary 
disease (COPD) in Chiang Mai, Thailand, than in patients 
without any history of chronic respiratory disease [4].
Diminished quality of life and poorer health outcomes 
are commonly reported in chronic disease patients 
with mental health comorbidities. In Thailand, epileptic 
patients with a history of anxiety and depression reported 
a significantly decreased quality of life [3]. In a 2012 
study, Lim et al. found that anxiety and depression among 
adults with chronic diseases in Singapore were associ-
ated with lower mental and physical functioning scores 
[9]. Notably, the researchers demonstrated that there is 
a multiplicative effect of chronic illnesses and anxiety 
and depression in decreasing quality of life. In a sample 
of Chinese adults with chronic obstructive pulmonary 
disorder, participants with anxiety and depression had a 
higher body mass index (BMI), degree of airflow obstruc-
tion, dyspnea and exercise capacity (BODE) index, 
shorter 6-min walk distance, more dyspnea and a greater 
quality of life score [10]. The evidence from Asian-wide 
studies reveals that chronic diseases interact with anxiety 
and depression to negatively impact mental and physical 
wellbeing [2–5, 9, 10]. However, there has been no study 
confirming this relationship in Cambodia.
People living with chronic diseases often feel stigma-
tized due to their conditions, in addition to experiencing 
anxiety and depression. More than 70% of people with 
epilepsy in China reported facing stigma in a 1995 study 
[11]. This is unsurprising, as studies have shown that 
over 60% of respondents in South Korea and over 85% 
in China disapprove of their children marrying some-
one with epilepsy [12, 13]. People living with hepatitis 
B in Malaysia reported fearing that disclosure of their 
status would result in being ostracized by the commu-
nity [14]. Senior chronic disease sufferers in South Korea 
reportedly worried about losing their jobs as a result of 
their illnesses, and thought they would be judged as not 
adequately managing their own health [15]. In a study of 
people with diabetes in Singapore, 12% were classified as 
stigma positive if they believed that revelation of their 
diabetes diagnosis would result in differential treatment 
by their colleagues [16]. The fear of stigma causes many 
people to conceal their disease [17].
Like the effects of mental health, these high rates of per-
ceived stigma negatively impacted patients’ reported qual-
ity of life [18]. Stigma positive individuals with diabetes in 
Singapore had a significantly higher number of median 
hospitalizations since 2001, as compared to stigma nega-
tive individuals [16]. They were also more likely to report 
their diabetes as affecting their work [16]. Over 25% of 
respondents in a study of hepatitis B sufferers in Malaysia 
felt unable to enjoy normal life activities since receiving 
their diagnosis [14]. Ng et al. [19] reported that high levels 
of perceived stigma about hepatitis B increased anxiety in 
those who had been newly diagnosed. Although there are 
many studies describing chronic disease related stigma 
and its effects on patients, no studies have further inves-
tigated how anxiety and depression may affect the stigma 
felt by those with chronic diseases.
Coping with chronic illnesses often involves major 
lifestyle changes. In order to treat pain associated with 
chronic diseases, many sufferers in Asia turn to tra-
ditional, complementary and alternative medicines 
(TCAM). TCAM use was reported at 64% among patients 
with chronic diseases in Malaysia [20], 60% among can-
cer patients in Thailand [21, 22] and 77% among adults 
with schizophrenia in Cambodia [23]. When chronic 
disease patients were asked about their medicine use in 
the previous year, 27% in Cambodia [24], 24% in Vietnam 
[24] and 23% in Singapore [25] reported using TCAM. A 
nationally representative household survey in Hong Kong 
found that people who consulted both western and tra-
ditional Chinese medicine practitioners were more likely 
to be older, be female, have a higher socio-economic sta-
tus and have a chronic disease [26]. Furthermore, adults 
with arthritis, musculoskeletal disorders and stroke in 
Singapore had four times the odds of using TCAM as 
compared to patients without those conditions. Dissat-
isfaction with care and strong adherence to traditional 
beliefs also predicted TCAM use [25]. Use of TCAM 
among people with chronic diseases has been well estab-
lished. However, how this relationship may vary based on 
anxiety and depression has not fully been explored.
The limited studies focusing on chronic diseases in 
Cambodia largely investigate disease management—
how alternative medicines [24], early detection [6, 27] 
and access to health services [28] differ among spe-
cific chronic disease patients. We have found no studies 
that integrate both chronic disease and mental health 
experiences of Cambodians. This study, then, fills two 
important gaps in the literature: (1) it investigates the 
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relationship between anxiety, depression and quality of 
life among Cambodians living with chronic illnesses and 
(2) it integrates the literatures of TCAM, chronic diseases 
and mental health to better understand how anxiety and 
depression alters the use of TCAM in this population. 
Understanding how quality of life and TCAM use varies 
for adults with anxiety and depression is essential to pro-
viding more comprehensive services to this population.
Methods
Study sites and participants
This cross-sectional survey was conducted as part of a 
multi-country study [24] with outpatients receiving care 
and treatment for chronic diseases in two urban and two 
rural primary health centers purposively selected based 
on the proportion of chronic disease patients who tend to 
frequent them from Phnom Penh, Kampong Cham and 
Siem Reap. The sample size included approximately 400 
patients per primary health center, for an estimated prev-
alence of anxiety and depressive symptoms of 20% with 
a precision of ± 2%. Every eligible patient was randomly 
selected at the health centers using a systematic random 
sampling procedure.
A patient would be invited to participate in the study if 
he/she was: (1) aged older than 21 years; (2) able to com-
municate in Khmer; (3) willing to participate in the study 
and could provide a verbal informed consent; (4) able to 
present themselves on the day of the interview; (5) physi-
cally and mentally stable to participate in the study and 
(6) receiving care and treatment at the selected health 
centers for one or more of 20 chronic conditions includ-
ing arthritis, asthma, cancer, cardiac arrhythmias, cardiac 
failure, COPD, coronary artery disease, diabetes mellitus, 
dyslipidaemia, epilepsy, gout and other musculoskeletal 
conditions, hypertension, kidney disease, liver disease, 
mental disorders, Parkinson disease, stomach and intesti-
nal disease, stroke and thyroid disease [25, 26].
Training and data collection
Data were collected in August and September 2014 by 
lay interviewers who underwent a 2-day training. The 
training covered necessary skills, including: understand-
ing the study protocol, questionnaire and consent form; 
mastering interview techniques; becoming familiar with 
confidentiality and privacy protection and the question-
naire administration and pretesting. Quality control skills 
such as checking the questionnaires after administration 
and resolving issues that might arise during the field-
work were also covered. Regular review sessions with 
interviewers were conducted during the survey period to 
review progress and communicate any problems or issues 
occurring during the data collection. The estimated time 
for each interview was approximately 30 min.
Variables and measurements
Socio‑demographic characteristics
Socio-demographic characteristics included age, gender, 
level of formal education completed, marital status, main 
occupation, main source of household income and type 
of neighborhood (urban or rural).
Use of TCAM
We used the I-CAM-Q, the international questionnaire 
to measure the use of TCAM that contains three sec-
tions. Section  1 asks about “visiting health care provid-
ers,” section  2 about the “use of herbal medicine and 
dietary supplements” and section 3 about “self-help prac-
tices.” The treatment modalities are presented in the form 
of a list, and respondents provide information on their 
usage over the previous 12 months (yes/no) [29].
Chronic disease related stigma
Chronic disease related stigma was measured using the 
Chronic Illness Anticipated Stigma Scale (CIASS) [30]. 
The CIASS measures anticipated stigma (i.e., expecta-
tions of prejudice, stereotyping and discrimination) 
among people living with chronic illnesses. It is a 12-item 
scale with three subscales differentiating among sources 
of anticipated stigma including friends, family members, 
colleagues and healthcare providers. Participants were 
asked to rate the likelihood that they would encounter 
these stigmatizing experiences in the future on a scale 
ranging from 1 (very unlikely) to 5 (very likely).
Quality of life
Quality of life was measured using the World Health 
Organization Quality-of-Life 8-question scale (WHO-
QOL-8) [31]. This consists of eight questions that were 
empirically derived from the WHOQOL-brief [32] 
addressing perceived aspects of the respondent’s quality 
of life in four principal domains: psychological, physi-
cal, social and environmental. Each question has five 
response options on a Likert-like scale, scored from 1 
(worst) to 5 (best); the summed score has the potential 
range of 8–40, with higher scores indicating better qual-
ity of life.
Anxiety and depression
Symptoms of anxiety and depression were assessed using 
the Hospital Anxiety and Depression Scale (HADS). 
The HADS was developed to measure symptoms of 
anxiety and depression in somatically ill patients [33]. 
The scale is divided into an anxiety subscale (HADS-A) 
and a depression subscale (HADS-D), both containing 
seven intermingled items. The participants are asked to 
evaluate how they felt during the last week. Each item is 
scored between 0 and 3, where 0 is asymptomatic and 3 
Page 4 of 13Yi et al. Int J Ment Health Syst  (2017) 11:58 
is considerable. The total score for each of the two sub-
scales is between 0 (no sign of illness) and 21 (severe 
degree of anxiety or depression) [33, 34]. The HADS has 
been extensively used in the field of cancer [35] and sev-
eral studies have shown good sensitivity and specificity 
with a cut-off score of 8+ for each of the two subscales 
[33, 36].
Data analyses
EpiData version 3 was used for double data entry 
(Odense, Denmark) and SPSS version 22 (IBM Cor-
poration, New York, USA) for all statistical analyses. In 
bivariate analyses, Student’s t test was used for continu-
ous variables, and Chi square test (or Fisher’s exact test 
when a cell count was smaller than five) for categorical 
variables to compare socio-demographic characteristics; 
use of traditional healers, herbal medicines, dietary sup-
plements and self-help practices; chronic illness antici-
pated stigma and quality of life among patients with and 
without anxiety and depressive symptoms.
A multivariate logistic regression model was separately 
constructed for anxiety and depressive symptoms. We 
first included all variables significantly associated with 
anxiety and depressive symptoms in bivariate analyses 
at a level of P value < 0.05 simultaneously in the model. 
Variables with a P value > 0.05 were then removed, and 
the model were refitted. The steps were repeated until 
all P values of the remaining variables were < 0.05 in the 
final model. Adjusted odds ratio (AOR) were obtained 
and presented with 95% confidence intervals (CI) and P 
values. Two-sided P values < 0.05 were used to indicate 
statistical significance.
Ethical considerations
This study was approved by the National Ethics Commit-
tee for Health Research, the Ministry of Health in Cam-
bodia (Ref: 0225NECHR). Participation in this study was 
voluntary, and a verbal consent was obtained from each 
participant after a detailed description of all study goals 
has been provided. Interviews were conducted in private 
locations, and confidentiality was protected by remov-
ing all personal identifiers from the questionnaires, field 
notes and the sampling frame. Participants were assigned 
a unique code. Researchers and data collectors were 
trained on confidentiality prior to data collection. Partici-
pants received a token of 3USD for time compensation.
Results
Socio‑demographic characteristics
Data were collected from 1602 patients. Sixteen patients 
refused the participation due to their time constrains 
and were replaced by the next patient on the patient list. 
Patients with mental disorders (n  =  74) were excluded 
from the analyses, leaving the final sample of 1528 
patients. Of the included sample, 77.2% were female, and 
62.2% were recruited from urban primary health centers 
with a mean age of 46.5  years (SD =  15.3). The major-
ity of them (75.9%) were married, 64.4% had a formal 
education of 5  years or less and 96.5% were Buddhist. 
Almost half (48.0%) were a housewife or homemaker, and 
only 19.5% were currently employed. Their self-reported 
chronic conditions for which they were receiving the care 
and treatment included stomach and intestinal diseases 
(71.5%), arthritis (25.2%), hypertension (25.1%), heart 
disease (15.6%), COPD (12.2%), diabetes mellitus (11.8%), 
migraine (10.3%), gout and other musculoskeletal condi-
tions (10.2%), kidney diseases (6.7%), asthma (2.7%), Par-
kinson’s disease (2.0%), dyslipidemia (2.0%), liver diseases 
(1.9%), cardiac arrhythmia (1.2%), thyroid (0.8%), stroke 
(0.4%), cancer (0.3%) and epilepsy (0.3%).
Comparisons of socio-demographic characteristics of 
the participants with and without anxiety and depressive 
symptoms are shown in Table  1. A significantly higher 
proportion of the participants with anxiety symptoms 
were older, female, separated or divorced, with lower 
level of education, currently unemployed or retired, 
receiving government or family support as main source 
of income and living in a rural area. Table 1 also shows 
that a significantly higher proportion of participants with 
depressive symptoms were older, widowed, with lower 
level of education, currently a housewife or homemaker 
or unemployed or retired, receiving formal salary as main 
source of income and living in a rural area.
Use of TCAM
As shown in Table  2, use of TCAM is common among 
patients with chronic conditions in this study. A signifi-
cantly higher proportion of the participants with anxiety 
symptoms reported the use of an herbalist, practicing 
visualization (imagery) and praying for own health. A sig-
nificantly lower proportion of participants with anxiety 
symptoms reported doing vigorous or moderate intensity 
sports or leisure activities in a typical week compared to 
those without anxiety symptoms. A significantly higher 
proportion of the participants with depressive symp-
toms reported the use of an herbalist, practicing of vis-
ualization (imagery) and praying for own health in the 
past 12  months compared to those without depressive 
symptoms. However, a significantly lower proportion of 
patients with depressive symptoms reported using home-
opathic remedies and vitamins or supplements in the 
past 12 months and walking or cycling for at least 10 min 
per day and doing vigorous or moderate intensity sports 
or leisure activities in a typical week.
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Chronic illness anticipated stigma
Table 3 shows comparison of chronic illness anticipated 
stigma among patients with and without anxiety and 
depressive symptoms. A significantly higher propor-
tion of patients with anxiety symptoms anticipated that 
a friend or family member will think that their illness is 
their fault; a friend or family member will not think as 
highly of them; a friend or family member will blame 
them; a friend or family member will be angry with them; 
someone at work will think that they cannot fulfill their 
work; someone at work will discriminate against them; a 
healthcare worker will blame them for not getting better 
Table 1 Comparison of  socio-demographic characteristics of  chronic disease patients with  and without  anxiety 
and depressive symptoms
Values are number of cases (%) for categorical variables and mean (± SD) for continuous variables
SD standard deviation
* Chi square test was used for categorical variables and t test for continuous variables
Socio‑demographic characteristics Total anxiety score Total depression score
< 8 ≥ 8 P value* < 8 ≥ 8 P value*
Age 0.004 < 0.001
 21–30 198 (35.4) 361 (64.6) 153 (27.4) 406 (72.6)
 31–40 4 (16.7) 20 (83.3) 4 (16.7) 20 (83.3)
 41–50 73 (26.6) 201 (73.4) 21 (7.7) 253 (92.3)
 51–60 97 (25.8) 279 (74.2) 20 (5.3) 356 (94.7)
 > 60 21 (27.5) 214 (72.5) 9 (3.1) 286 (96.9)
Sex < 0.001 0.69
 Male 152 (43.6) 197 (56.4) 45 (12.9) 304 (87.1)
 Female 301 (25.5) 878 (81.7) 162 (13.7) 1017 (86.3)
Marital status 0.001 < 0.001
 Never married 51 (44.0) 65 (56.0) 50 (43.1) 66 (56.9)
 Married 342 (29.5) 817 (70.5) 144 (12.4) 1015 (87.6)
 Separated/divorced 14 (21.5) 51 (78.5) 8 (12.3) 58 (87.7)
 Widowed 46 (24.5) 142 (75.5) 5 (2.7) 183 (97.3)
Formal education completed < 0.001 < 0.001
 No schooling 104 (22.1) 366 (77.9) 35 (7.4) 435 (92.6)
 1–5 years 147 (28.6) 367 (71.4) 55 (10.7) 459 (89.3)
 6–9 years 120 (35.8) 216 (64.3) 54 (16.1) 282 (83.9)
 10–12 years 53 (34.4) 101 (65.6) 27 (17.5) 127 (82.5)
 Higher education 27 (53.7) 26 (46.3) 36 (66.7) 18 (33.3)
Current employment < 0.001 < 0.001
 Housewife/homemaker 217 (29.6) 577 (70.4) 72 (9.8) 662 (90.2)
 Unemployed/retired 13 (24.1) 41 (75.9) 6 (11.1) 48 (88.9)
 Employed 106 (35.6) 192 (64.4) 36 (12.1) 262 (87.9)
 Self-employed 69 (33.7) 136 (66.3) 51 (24.9) 154 (75.1)
 Students 23 (43.4) 30 (56.6) 32 (60.4) 21 (39.6)
 Other 25 (13.6) 159 (86.4) 10 (5.4) 174 (94.6)
Main source of household income < 0.001 < 0.001
 Formal salary 47 (34.6) 89 (65.4) 9 (6.6) 127 (93.4)
 Family support 261 (31.1) 578 (68.9) 125 (14.9) 714 (85.1)
 NGO support 59 (43.4) 77 (56.6) 46 (33.8) 90 (66.2)
 Government support 18 (29.0) 44 (71.0) 14 (22.6) 48 (77.4)
 Other 68 (19.2) 287 (80.8) 13 (3.7) 342 (96.3)
Type of neighborhood < 0.001 < 0.001
 Rural 237 (24.9) 713 (75.1) 34 (3.6) 916 (96.4)
 Urban 216 (37.4) 362 (62.6) 173 (29.9) 405 (70.1)
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Table 2 Comparison of  use of  traditional, complementary and  alternative medicine in  past 12  months among  chronic 
disease patients with and without anxiety and depressive symptoms
Total anxiety score Total depression score
< 8 ≥ 8 P value* < 8 ≥ 8 P value*
Herbalist 0.001 < 0.001
 No 397 (32.3) 832 (67.7) 199 (16.2) 1030 (83.8)
 Yes 56 (18.7) 243 (81.3) 8 (2.7) 291 (97.3)
Spiritual healer 0.64 0.67
 No 452 (29.7) 1071 (70.3) 206 (13.5) 1317 (86.5)
 Yes 1 (20.0) 4 (80.0) 1 (20.0) 4 (80.0)
Acupuncturist 0.14 0.76
 No 437 (30.0) 1018 (70.0) 198 (13.6) 1357 (86.4)
 Yes 16 (21.9) 57 (78.1) 9 (12.3) 64 (87.7)
Chiropractor 0.91 0.15
 No 436 (29.6) 1036 (70.4) 203 (13.8) 1269 (86.2)
 Yes 17 (30.4) 39 (64.6) 4 (7.1) 52 (92.9)
Yoga practitioner 0.32 0.06
 No 444 (29.5) 1061 (70.5) 207 (13.8) 1298 (86.2)
 Yes 9 (39.1) 14 (60.9) 0 (0.0) 23 (100.0)
Massage therapist 0.62 0.67
 No 441 (29.6) 1051 (70.4) 203 (13.6) 1289 (97.6)
 Yes 12 (33.3) 24 (66.7) 4 (11.1) 32 (88.9)
Herbal medicine use 0.10 0.72
 No 267 (31.3) 585 (68.7) 113 (13.3) 739 (86.7)
 Yes 186 (27.5) 490 (72.5) 94 (13.9) 582 (86.1)
Using vitamins/supplements 0.68 < 0.001
 No 347 (29.4) 834 (70.6) 103 (8.7) 1078 (91.3)
 Yes 106 (30.5) 241 (69.6) 104 (30.0) 243 (70.0)
Using homeopathic remedies 0.86 < 0.001
 No 437 (29.6) 1039 (70.4) 186 (12.6) 1290 (87.4)
 Yes 16 (30.8) 36 (69.2) 21 (40.4) 31 (59.6)
Self-help practices—meditation 0.18 0.34
 No 419 (30.1) 971 (69.9) 192 (13.8) 1198 (86.2)
 Yes 34 (24.6) 104 (75.4) 15 (10.9) 123 (89.1)
Self-help practices—yoga 0.79 0.07
 No 426 (29.7) 1007 (70.3) 200 (14.0) 1233 (86.0)
 Yes 27 (28.4) 68 (71.6) 7 (7.4) 88 (92.6)
Self-help practices—qigong (energy healing) 0.21 0.39
 No 446 (29.5) 1066 (70.5) 206 (13.6) 1306 (86.4)
 Yes 7 (43.8) 9 (56.2) 1 (6.3) 15 (93.7)
Self-help practices—relaxation techniques 0.90 0.91
 No 372 (29.7) 880 (70.3) 169 (13.5) 1083 (86.5)
 Yes 81 (29.3) 195 (70.7) 38 (13.8) 238 (86.2)
Self-help practices—visualization (imagery) < 0.001 < 0.001
 No 378 (33.1) 764 (66.9) 190 (16.6) 952 (83.4)
 Yes 75 (19.4) 311 (80.6) 17 (4.4) 369 (95.6)
Self-help practices—traditional healing ceremony 0.85 0.11
 No 444 (29.7) 1052 (70.3) 206 (13.8) 1290 (86.2)
 Yes 9 (28.1) 23 (71.9) 1 (3.1) 31 (96.9)
Self-help practices—praying for own health < 0.001 < 0.001
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and a healthcare worker will think that they are a bad 
patient. A significantly higher proportion of the partici-
pants with depressive symptoms reported that a friend 
or family member will blame them, their employer will 
assign a project to someone else and their employer will 
not promote them.
Quality of life
Comparison of several items of quality of life among 
patients with and without anxiety and depressive symp-
toms are shown in Table  4. A significantly higher pro-
portion of patients with anxiety symptoms reported that 
their quality of life was poor or very poor. They were sig-
nificantly more likely to report that they were dissatisfied 
with their own health, themselves and the current living 
place conditions. They were also significantly less likely 
to report that they had enough energy for everyday life 
and money to meet daily needs. Similarly, a significantly 
higher proportion of patients with depressive symptoms 
reported that their quality of life was poor or very poor; 
that they were dissatisfied with their own health, ability 
to perform daily activities, themselves, personal relation-
ships and current living place conditions; and that they 
did not have enough energy for everyday life and money 
to meet daily needs.
Factors associated with anxiety and depressive symptoms
The results of multivariate logistic regression analyses 
are shown in Table 5. After controlling for other covari-
ates, patients with anxiety symptoms remained signifi-
cantly more likely to be female (AOR  =  2.17, 95% CI 
1.61–2.93) and less likely to report having completed 
6–9  years of formal education (AOR  =  0.65, 95% CI 
0.46–0.91). Regarding the use of TCAM, patients with 
anxiety symptoms remained significantly more likely to 
report using an herbalist (AOR  =  1.65, 95% CI 1.17–
2.31), practicing visualization (AOR  =  2.35, 95% CI 
1.62–3.41) and praying for own health (AOR  =  1.81, 
95% CI 1.33–2.48) in the past 12  months. Moreover, 
they were significantly less likely to agree that they 
were satisfied with their own health (AOR = 0.11, 95% 
CI 0.01–0.81), satisfied with themselves (AOR =  0.19, 
95% CI 0.04–0.89), had enough energy for their every-
day life (AOR =  0.57, 95% CI 0.39–0.82), had enough 
money to meet their daily needs (AOR = 0.55, 95% CI 
0.41–0.73) and were satisfied with the conditions of 
their current living place conditions (AOR = 0.58, 95% 
CI 0.35–0.96).
Table 5 also shows that patients with depressive symp-
toms remained significantly more likely to be in the 
age group of 41–50 (AOR  =  2.43, 95% CI 1.34–4.43) 
and 51–60 (AOR  =  2.37, 95% CI 1.30–4.32) and to be 
married (AOR  =  4.96, 95% CI 2.65–9.28), separated/
divorced (AOR  =  3.05, 95% CI 1.01–9.24) or widowed 
(AOR  =  11.84, 95% CI 3.54–39.63) compared to those 
without depressive symptoms. Patients with depressive 
symptoms remained significantly more likely to report 
using an herbalist (AOR = 3.68, 95% CI 1.61–8.43), prac-
ticing visualization (AOR  =  5.02, 95% CI 2.34–10.75) 
and praying for their own health (AOR =  4.25, 95% CI 
2.11–8.57), but less likely to report using vitamins or 
supplements (AOR  =  0.50, 95% CI 0.33–0.85) in the 
past 12  months. Regarding quality of life, patients with 
depressive symptoms remained significantly less likely 
to agree that they had enough energy for their everyday 
life (AOR  =  0.18, 95% CI 0.08–0.35) and had enough 
money to meet their daily needs (AOR =  0.45, 95% CI 
0.30–0.69).
Values are number of cases (%)
* Chi square test (or Fisher’s exact test when a cell count was smaller than five) was used
Table 2 continued
Total anxiety score Total depression score
< 8 ≥ 8 P value* < 8 ≥ 8 P value*
 No 346 (35.0) 642 (65.0) 184 (18.6) 804 (81.4)
 Yes 107 (19.8) 443 (80.2) 23 (4.3) 517 (95.7)
Walk or use a bicycle for at least 10 min 0.28 < 0.001
 No 286 (30.7) 647 (69.3) 75 (8.0) 858 (92.0)
 Yes 167 (28.1) 428 (71.9) 132 (22.2) 463 (77.8)
Do vigorous intensity sports or leisure activities 0.01 < 0.001
 No 415 (29.1) 1013 (70.9) 165 (11.6) 1363 (88.4)
 Yes 38 (41.8) 53 (58.2) 40 (44.0) 51 (56.0)
Do moderate intensity sports or leisure activities 0.04 < 0.001
 No 366 (28.6) 912 (71.4) 124 (9.7) 1154 (90.3)
 Yes 87 (34.8) 163 (65.2) 83 (33.2) 167 (66.8)
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Discussion
The results of this study are consistent with other stud-
ies in the region [2, 3, 9, 10, 37], which have found that 
patients with anxiety and depressive symptoms are 
likely to utilize TCAM, report a low quality of life and 
great stigma related to their chronic conditions. Like 
preceding literature, our study found that being female 
did statically increase the chances of having anxiety 
symptoms, but our study found no association between 
depressive symptoms and gender, unlike other work 
in the field. This work also reinforced the theme that 
anxiety and depression can worsen chronic disease out-
comes. Our study showed that those with anxiety and 
depressive symptoms were less likely to report having 
less energy, and that they lacked the financial means of 
support.
Table 3 Comparison of  chronic illness anticipated stigma among  patients with  and without  anxiety and  depressive 
symptoms
Values are number of cases (%)
* Chi square test (or Fisher’s exact test when a cell count was smaller than five) was used
Total anxiety score Total depression score
< 8 ≥ 8 P value* < 8 ≥ 8 P value*
Friends/family members will think that your illness is your fault < 0.001 0.09
 No 432 (32.0) 916 (68.0) 190 (14.1) 1158 (85.9)
 Yes 21 (11.7) 159 (88.3) 17 (9.4) 163 (90.6)
Friends/family members will not think as highly of you < 0.001 0.13
 No 433 (31.2) 956 (68.8) 194 (14.0) 1195 (86.0)
 Yes 20 (14.4) 919 (85.6) 13 (9.4) 126 (90.6)
Friends/family members will blame you < 0.001 0.02
 No 434 (31.9) 926 (68.1) 194 (14.3) 1166 (85.7)
 Yes 19 (11.3) 149 (88.7) 13 (7.7) 155 (92.3)
Friends/family members will be angry with you < 0.001 0.02
 No 437 (31.9) 934 (68.1) 195 (14.2) 1176 (85.8)
 Yes 16 (10.2) 141 (89.8) 12 (7.6) 145 (92.4)
Someone at work will think that you cannot fulfill your work 0.03 0.19
 No 449 (30.0) 1046 (70.0) 200 (13.4) 1295 (86.6)
 Yes 4 (12.1) 21 (87.9) 7 (21.2) 26 (78.8)
Your employer will assign a project to someone else 0.14 0.03
 No 448 (29.9) 1113 (70.8) 199 (13.3) 1300 (86.7)
 Yes 5 (17.2) 24 (82.8) 8 (27.6) 21 (72.4)
Someone at work will discriminate against you 0.03 0.06
 No 450 (30.0) 1051 (70.0) 200 (13.3) 1301 (86.7)
 Yes 3 (11.1) 24 (88.9) 7 (25.9) 24 (74.1)
Your employer will not promote you 0.07 0.03
 No 450 (29.9) 1053 (70.1) 200 (13.3) 1303 (86.7)
 Yes 3 (12.0) 22 (88.0) 7 (28.0) 18 (72.0)
Healthcare workers will blame you for not getting better 0.03 0.89
 No 440 (30.2) 1017 (69.8) 197 (13.5) 1260 (86.5)
 Yes 13 (18.3) 58 (81.7) 10 (14.1) 61 (85.9)
Healthcare worker will be frustrated with you 0.18 0.57
 No 432 (30.0) 1006 (70.0) 193 (13.4) 1245 (86.6)
 Yes 21 (23.3) 69 (76.7) 14 (18.6) 76 (84.4)
Healthcare workers will give you poor care 0.11 0.70
 No 441 (30.0) 1028 (70.0) 200 (13.6) 1269 (86.4)
 Yes 12 (20.3) 47 (79.7) 7 (11.9) 52 (88.1)
Healthcare workers will think that you are a bad patient 0.03 0.70
 No 443 (30.2) 1026 (69.8) 200 (13.6) 1269 (86.4)
 Yes 10 (16.9) 49 (83.1) 7 (11.9) 52 (88.1)
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Like a 2012 study of COPD sufferers [10] and a 2014 
study of end-stage renal disease patients [2] in China, we 
found that being female was significantly associated with 
anxiety symptoms. Whereas Hou et  al. [2] found that 
being male was associated with depression, our study dif-
fers in that we did not find that any gender was statisti-
cally significantly associated with depressive symptoms. 
Women in Cambodian society are responsible for the 
general family welfare. That women with chronic diseases 
are more likely to suffer anxiety symptoms may be related 
to the stress around simultaneously balancing a chronic 
disease and family caretaking. While women worldwide 
typically report higher rates of depression, in our study 
this was not the case. In Cambodia, as a result of the 
genocide, rates of depression and trauma-related mental 
health disorders is higher in affected populations across 
both genders—higher even compared to other post-con-
flict countries [38]. In our study, the mean age of those 
reporting higher rates of depressive symptoms was sig-
nificantly higher than those reporting lower rates which 
may indicate that participants in this group are more 
likely to have been affected by the 1975–1979 genocide. 
Table 4 Comparison of  quality of  life among  chronic disease patients with  and without  anxiety and  depressive symp-
toms
Values are number of cases (%)
* Chi square test (or Fisher’s exact test when a cell count was smaller than five) was used
Quality of life Total anxiety score Total depression score
< 8 ≥ 8 P value* < 8 ≥ 8 P value*
Self-rated quality of life < 0.001 < 0.001
 Poor/very poor 37 (19.4) 154 (80.6) 8 (4.2) 183 (95.8)
 Neither poor nor good 175 (27.5) 461 (72.5) 87 (13.7) 449 (86.3)
 Good/very good 241 (34.4) 460 (65.6) 112 (16.0) 589 (84.0)
Satisfaction with your own health < 0.001 0.001
 Dissatisfied 1 (1.8) 54 (98.2) 3 (5.5) 52 (94.5)
 Neutral 205 (28.5) 515 (71.5) 77 (10.7) 643 (89.3)
 Satisfied 247 (32.8) 506 (67.2) 127 (16.9) 626 (83.1)
Having enough energy for your everyday life 0.001 < 0.001
 Not at all/a little 135 (25.1) 402 (74.9) 9 (1.7) 528 (98.3)
 Moderately 153 (28.9) 376 (71.1) 54 (10.2) 475 (89.8)
 Mostly/completely 165 (36.7) 297 (64.3) 144 (31.2) 318 (68.8)
Satisfaction with ability to perform your daily activities 0.38 < 0.001
 Dissatisfied 13 (22.4) 45 (77.6) 12 (20.7) 46 (79.3)
 Neutral 181 (29.0) 443 (71.0) 24 (3.8) 600 (96.2)
 Satisfied 269 (30.6) 587 (69.4) 171 (20.2) 675 (79.8)
Satisfaction with yourself 0.001 <0.001
 Dissatisfied 2 (4.7) 41 (95.3) 2 (4.7) 41 (95.3)
 Neutral 222 (30.3) 511 (69.7) 77 (10.5) 656 (89.5)
 Satisfied 229 (30.5) 528 (69.5) 128 (17.0) 624 (83.0)
Satisfaction with your personal relationships 0.17 < 0.001
 Dissatisfied 5 (25.0) 15 (75.0) 5 (25.0) 15 (75.0)
 Neutral 204 (32.2) 429 (67.8) 59 (9.3) 574 (90.7)
 Satisfied 244 (27.9) 631 (72.1) 143 (16.3) 732 (83.7)
Having enough money to meet your daily needs < 0.001 < 0.001
 Not at all/a little 271 (24.6) 831 (75.4) 88 (8.0) 1014 (92.0)
 Moderately 177 (42.3) 241 (57.7) 113 (27.0) 305 (73.0)
 Mostly/completely 5 (62.5) 3 (37.5) 6 (75.0) 2 (25.0)
Satisfaction with your currently living place conditions 0.03 < 0.001
 Dissatisfied 25 (17.2) 105 (80.8) 22 (16.9) 108 (83.1)
 Neutral 120 (30.5) 274 (69.5) 27 (6.9) 367 (93.1)
 Satisfied 308 (30.7) 696 (69.3) 158 (15.7) 846 (84.3)
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This may account for the lack of the gender difference in 
contrast to most other places in the world.
Other studies demonstrated that chronic disease 
patients with depressive symptoms were more likely to 
have lower incomes [8, 10, 39]. Although our study did 
not include level of income as a covariate, one of the 
quality of life measures was whether or not the respond-
ent had enough money to meet daily needs. Participants 
with anxiety and depressive symptoms were both sig-
nificantly less likely to report having moderately enough 
money to meet their daily needs. Although we cannot 
infer that chronic diseases caused anxiety or depres-
sive symptoms among study participants, the effect on 
income may reflect that symptoms of anxiety or depres-
sion compound the work-related challenges associated 
with chronic diseases. It may be even more difficult for 
chronic disease sufferers with anxiety or depression to 
maintain stable employment. This association may also 
represent the stress associated with finding the resources 
to pay for the maintenance of a chronic disease. Out-of-
pocket payments for health care are the largest expense 
for households in Cambodia after food expenditures; this 
places an enormous burden on poorer families [40].
One of the most important findings from the litera-
ture was that anxiety and depression not only negatively 
impact mental health of patients with chronic diseases, 
but also worsened health outcomes [9, 10]. Our study 
may have reinforced this conclusion; respondents with 
anxiety and depressive symptoms were significantly less 
likely to report having enough energy for their everyday 
life. In bivariate analyses, participants with depressive 
Table 5 Factors associated with  anxiety and  depressive 
symptoms in multivariate logistic regression models
Variables 
in final  modelsa
Anxiety score (< 8 
vs. ≥ 8)
Depression score (< 8 
vs. ≥ 8)
AOR (95% CI) P value AOR (95% CI) P value
Age
 21–30 Reference
 31–40 0.71 (0.18–2.78) 0.62
 41–50 2.43 (1.34–4.43) 0.004
 51–60 2.37 (1.30–4.32) 0.005
 > 60 2.26 (1.00–5.13) 0.05
Gender
 Male Reference
 Female 2.17 (1.61–2.93) <0.001
Marital status
 Never married Reference
 Married 4.96 (2.65–9.28) < 0.001
 Separated/
divorced
3.05 (1.01–9.24) 0.04
 Widowed 11.84 (3.54–
39.63)
< 0.001
Formal education completed
 No schooling Reference
 1–5 years 0.79 (0.58–1.07) 0.13
 6–9 years 0.65 (0.46–0.91) 0.01
 10–12 years 0.75 (0.49–1.17) 0.21
 Higher educa-
tion
0.53 (0.28–1.01) 0.05
Using an herbalist
 No Reference Reference
 Yes 1.65 (1.17–2.31) 0.004 3.68 (1.61–8.43) 0.002
Self-help practices—visualization (imagery)
 No Reference Reference
 Yes 2.35 (1.62–3.41) <0.001 5.02 (2.34–10.75) <0.001
Self-help practices—praying for own health
 No Reference Reference
 Yes 1.81 (1.33–2.48) <0.001 4.25 (2.11–8.57) <0.001
Using vitamins/supplements
 No Reference
 Yes 0.50 (0.33–0.85) 0.001
Satisfaction with your own health
 Dissatisfied Reference
 Neutral 0.14 (0.02–1.09) 0.06
 Satisfied 0.11 (0.01–0.81) 0.03
Satisfaction with yourself
 Dissatisfied Reference
 Neutral 0.19 (0.04–0.89) 0.04
 Satisfied 0.23 (0.05–1.06) 0.06
Having enough energy for your everyday life
 Not at all/a 
little
Reference Reference
 Moderately 0.92 (0.68–1.24) 0.58 0.18 (0.08–0.35) <0.001
AOR adjusted odds ratio, CI confidence interval
a Variables in the table were the ones that remained statistically associated with 
anxiety and depressive symptoms in the final multivariate logistic regression 
model after several steps of model fitting
Table 5 continued
Variables 
in final  modelsa
Anxiety score (< 8 
vs. ≥ 8)
Depression score (< 8 
vs. ≥ 8)
AOR (95% CI) P value AOR (95% CI) P value
 Mostly/com-
pletely
0.57 (0.39–0.82) 0.002 0.04 (0.02–0.08) <0.001
Having enough money to meet your needs
 Not at all/a 
little
Reference Reference
 Moderately 0.55 (0.41–0.73) <0.001 0.45 (0.30–0.69) 0.002
 Mostly/com-
pletely
0.61 (0.14–2.74) 0.52 0.32 (0.05–1.99) 0.22
Satisfaction with your current living place conditions
 Dissatisfied Reference
 Neutral 0.50 (0.29–0.85) 0.01
 Satisfied 0.58 (0.35–0.96) 0.04
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symptoms were also significantly less likely to get 
involved in physical activities such as walking or using a 
bicycle and doing vigorous or moderate intensity sports 
or leisure activities. While our study design makes it dif-
ficult to know for certain if the chronic disease preceded 
the anxiety and depressive symptoms or the other way 
around, experiencing comorbid depressive symptoms 
was the cause of less energy and physical activity, as the 
greater Asian literature predicted [9, 10].
In the 2016 study about TCAM use in Cambodia, Viet-
nam and Thailand, Peltzer et  al. [24] reported that over 
20% of Cambodian participants visited an herbalist in 
the last year. Almost half reported using an herbal medi-
cine, and over 22% took vitamins or supplements in the 
last year. Over 35% of Cambodians prayed for their own 
health; almost one-third used visualization techniques and 
almost one-fifth used relaxation techniques to alleviate 
symptoms [24]. In multivariate analyses of all participants 
from the three countries, having two or more chronic con-
ditions was associated with use of TCAM products [24]. 
Lee et al. [25] found that TCAM use was significantly asso-
ciated with arthritis, musculoskeletal disorders and stroke 
in a Singaporean study population. Our study adds further 
understanding to factors associated with TCAM use and 
patients with chronic diseases. We found that respondents 
who reported anxiety or depressive symptoms were more 
likely to use an herbalist, practice visualization and pray 
for their own health in the last year. Participants who had 
depressive symptoms were also more likely to report using 
vitamins or supplements in the last year.
Other studies found that TCAM use was related to dis-
satisfaction of medical care [25]. Feeling depressed or 
anxious about one’s life may compound frustrations with 
one’s chronic disease. If respondents felt more anxious or 
depressed about their condition, then it could lead them 
to seek alternative methods of disease treatment and 
pain alleviation. Our study confirmed that patients with 
anxiety and depressive symptoms reported worse qual-
ity of life and less energy to conduct their everyday lives, 
both of which could impact a patient’s attitude about the 
assigned medical treatment.
Limitations of the study
There are several important limitations to this study. 
This was a cross-sectional study and therefore, we are 
unable to draw causal inferences from our findings. Sec-
ond, all measures were self-reported and not diagnosed 
by a medical or mental health professional. As a result, 
there may be biases in reporting that may lead to both 
underreporting and over-reporting of certain variables 
and also misclassification of disease and non-disease. 
This misclassification is likely to be unevenly distributed 
between diseases that are easier to self-diagnose such as 
gastrointestinal disorders and those that are more diffi-
cult such as cancers. We used validated scales to measure 
both outcomes to address this problem. All scales used 
in this study were developed by international panels that 
included Cambodian and/or Southeast Asian participants 
and have been successfully used in Cambodian popula-
tions. But despite successful usage of these scales, there 
may be linguistic and cultural factors that can affect the 
accuracy of such components as cut-points for anxiety 
and depressive symptoms. The final limitation concerns 
the generalizability of the findings to patients in other set-
tings because our study participants were recruited from 
only two rural and two urban primary health centers.
Conclusions
This study helps to understand more about how anxi-
ety and depression relate to motivation to seek and uti-
lize TCAM among patients with chronic diseases and 
the ways in which they use TCAM. Patients with anxi-
ety symptoms reported more stigmatization about their 
disease from various sources including family, friends, 
work and health providers. Patients with anxiety and 
depressive symptoms were found to utilize herbalists, 
visualization and prayer, while those with depressive 
symptoms also had an increased utilization of vitamins 
and supplements.
The findings are important because healthcare pro-
viders need to ask key questions during the history and 
physical examination when treating patients to under-
stand what types of treatments the patients have previ-
ously tried or are utilizing. This information is important 
so that the healthcare system can address the full scope of 
the patient’s complaints while working with them to craft 
a plan that will take the patient’s desires for treatment, 
treatment methods and means into account especially 
if the patient has anxiety or depression. Furthermore, 
results of this study suggest that, in routine visits for 
chronic medical conditions (such as diabetes for exam-
ple), a quick screen for anxiety or depressive symptoms 
and utilization of TCAM would be warranted.
Future areas of study would include the association 
between income and depression and anxiety linked to 
chronic diseases. This study found that those with anxi-
ety and depressive symptoms reported more perceived 
financial instability and solvency. In Cambodia, most 
medical expenses are paid for out of pocket and are the 
second highest household expense. A study examin-
ing the role of cost of care and poverty level leading to 
TCAM utilization might further shed light on the field. 
Additionally, the study sample, though random in design, 
was overwhelmingly female; thus a study examining the 
use of TCAM by gender and for what reason might also 
contribute to this body of knowledge.
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